For the second time in 19 months, a federal judge in New York has dismissed a lawsuit claiming that Bristol Myers Squibb slow ...
District Judge Jesse Furman ruled that the plaintiff, UMB Bank, does not have standing to bring the case against Bristol ...
UMB Bank NA filed suit against Bristol Myers in 2021, alleging the company intentionally slow-rolled the approval process for ...
Bristol Myers Squibb won a legal victory as a New York judge dismissed a $6.4 billion lawsuit filed by UMB Bank on behalf of ...
Patients who received subcutaneous daratumumab plus bortezomib, lenalidomide, and dexamethasone (VRd) had better outcomes ...
Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation company, today announced that it has appointed Jorge F. DiMartino, M.D., Ph.D., as Chief Medical Officer and Executive ...
Among patients with Crohn's disease, anti-TNF therapy failed to achieve remission at 3 years, and high drug concentrations early in treatment were linked to greater probability of sustained remission.
The latest health news highlights include Kailera Therapeutics' $400 million funding, potential CVS Health restructuring, ...
DelveInsight's PLK-1 Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, ...
The attack, which ended shortly after it began on Tuesday evening, was a sharp escalation in the long-simmering conflict between Israel and Iran and could tip the region further into turmoil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback